✦ LIBER ✦

A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer

✍ Scribed by Athanasios G. Pallis; Alexandra Voutsina; Nikolaos Kentepozidis; Stylianos Giassas; Pavlos Papakotoulas; Sofia Agelaki; Kostas Tryfonidis; Athanasios Kotsakis; Lambros Vamvakas; Nikolaos Vardakis; Vassilis Georgoulias

Book ID: 113544781
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 374 KB
Volume: 13
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2011.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity and safety of erlotinib as seco

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

✍ David Rossi; Donatella Dennetta; Marcello Ugolini; Vincenzo Catalano; Paolo Ales 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 129 KB

A Phase II Study of Erlotinib as a First

A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors

✍ Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Tak Yun; Heung Tae Kim; Eun Kyung Cho; Jo 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 62 KB

A phase II trial of erlotinib in patient

A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer

✍ Takashi Kobayashi; Tomonobu Koizumi; Toshihide Agatsuma; Masanori Yasuo; Kenji T 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 271 KB

Clinical effect of erlotinib as first-li

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer

✍ Xin-Hua Xu; Jin Su; Xiang-Yang Fu; Feng Xue; Qiao Huang; Dao-Jun Li; Ming-Qian L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 232 KB

Randomized Phase II Trial of Onartuzumab

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Ervin, T. J.; Ramlau, R. A.; Daniel, D. B.; Goldschmidt, J. H.; B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Front-line treatment of advanced non-sma

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

✍ Georgoulias, V; Kourousis, Ch; Androulakis, N; Kakolyris, S; Dimopoulos, MA; Pap 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB